Effect of chemoradiotherapy and neoadjuvant chemoradiotherapy in resectable pancreatic cancer: a systematic review and meta-analysis

@article{Xu2013EffectOC,
  title={Effect of chemoradiotherapy and neoadjuvant chemoradiotherapy in resectable pancreatic cancer: a systematic review and meta-analysis},
  author={Chen Xu and Xiu Juan Xue and Nai-xin Liang and Dianguo Xu and Feng Liu and Xun Sean Yu and Jun D. Zhang},
  journal={Journal of Cancer Research and Clinical Oncology},
  year={2013},
  volume={140},
  pages={549-559}
}
Controversy remains existed whether chemoradiotherapy (CRT), especially neoadjuvant chemoradiotherapy (neoadjuvant CRT) achieves a significant benefit in resectable pancreatic cancer (PC) treatment. In this meta-analysis, we aimed to clarify the benefits of CRT and neoadjuvant CRT in resectable PC. Eligible trials were identified from MEDLINE, EMBASE, Cochrane center, China National Knowledge Internet and Wanfang database since their inception to July 31, 2013. Only patients with resectable PC… CONTINUE READING
12 Citations
52 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 12 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 52 references

willett CG, white RR (2012) Does preoperative therapy optimize outcomes in patients with resectable pancreatic cancer

  • KT Papalezova, DS Tyler, +5 authors TN Pappas
  • J Surg Oncol
  • 2012
Highly Influential
8 Excerpts

Similar Papers

Loading similar papers…